SYK and breast carcinoma: The present study aims to determine Syk mRNA expression in both breast cancer and adjacent normal breast tissue (ANCT) using RT-PCR methodology and correlate the expression in cancer with patients' age, tumour size, tumour grade, estrogen and progesterone receptor status, lymph node metastasis, vascular invasion and clinical outcome.